Qi N. Cui

1.3k total citations
57 papers, 760 citations indexed

About

Qi N. Cui is a scholar working on Ophthalmology, Radiology, Nuclear Medicine and Imaging and Molecular Biology. According to data from OpenAlex, Qi N. Cui has authored 57 papers receiving a total of 760 indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Ophthalmology, 24 papers in Radiology, Nuclear Medicine and Imaging and 8 papers in Molecular Biology. Recurrent topics in Qi N. Cui's work include Glaucoma and retinal disorders (33 papers), Retinal Diseases and Treatments (20 papers) and Corneal surgery and disorders (17 papers). Qi N. Cui is often cited by papers focused on Glaucoma and retinal disorders (33 papers), Retinal Diseases and Treatments (20 papers) and Corneal surgery and disorders (17 papers). Qi N. Cui collaborates with scholars based in United States, China and Japan. Qi N. Cui's co-authors include Joshua L. Dunaief, Roland Lee, Jacob Sterling, Ahmara G. Ross, Travis C. Porco, Mingguang He, Shan C. Lin, Ian R. Gorovoy, Shan C. Lin and Gary D. Paige and has published in prestigious journals such as PLoS ONE, Journal of Neurophysiology and Ophthalmology.

In The Last Decade

Qi N. Cui

54 papers receiving 750 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Qi N. Cui United States 16 505 317 106 105 72 57 760
Fleur O’Hare Australia 13 327 0.6× 145 0.5× 252 2.4× 51 0.5× 23 0.3× 31 602
Christine Adrion Germany 17 413 0.8× 219 0.7× 255 2.4× 390 3.7× 21 0.3× 26 1.0k
Akira Imai Japan 16 293 0.6× 221 0.7× 171 1.6× 21 0.2× 45 0.6× 40 594
Mauro Cellini Italy 19 830 1.6× 404 1.3× 238 2.2× 110 1.0× 14 0.2× 64 1.2k
Raquel Alarcia Spain 14 565 1.1× 266 0.8× 437 4.1× 47 0.4× 16 0.2× 30 1.0k
We Fong Siah Ireland 15 173 0.3× 146 0.5× 121 1.1× 62 0.6× 19 0.3× 35 615
Shota Kojima Japan 16 496 1.0× 262 0.8× 157 1.5× 79 0.8× 7 0.1× 41 672
Fumihiko Mabuchi Japan 24 1.2k 2.5× 555 1.8× 431 4.1× 105 1.0× 9 0.1× 52 1.4k
Jes Fagerness United States 7 352 0.7× 230 0.7× 206 1.9× 18 0.2× 6 0.1× 7 685
Gail Maconachie United Kingdom 18 341 0.7× 190 0.6× 278 2.6× 115 1.1× 10 0.1× 33 773

Countries citing papers authored by Qi N. Cui

Since Specialization
Citations

This map shows the geographic impact of Qi N. Cui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qi N. Cui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qi N. Cui more than expected).

Fields of papers citing papers by Qi N. Cui

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qi N. Cui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qi N. Cui. The network helps show where Qi N. Cui may publish in the future.

Co-authorship network of co-authors of Qi N. Cui

This figure shows the co-authorship network connecting the top 25 collaborators of Qi N. Cui. A scholar is included among the top collaborators of Qi N. Cui based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qi N. Cui. Qi N. Cui is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
3.
Tauqeer, Zujaja, et al.. (2024). Glucagon-Like Peptide-1 Receptor Agonists are Not Associated with an Increased Risk of Progressing to Vision-Threatening Diabetic Retinopathy. Ophthalmic Epidemiology. 32(4). 390–393. 5 indexed citations
5.
Chan, Lilian, Marlene R. Moster, Amanda K. Bicket, et al.. (2023). New Devices in Glaucoma. Ophthalmology and Therapy. 12(5). 2381–2395. 7 indexed citations
6.
Khan, Reas S., Kimberly Dine, Qi N. Cui, et al.. (2023). Cell-Specific Expression of Human SIRT1 by Gene Therapy Reduces Retinal Ganglion Cell Loss Induced by Elevated Intraocular Pressure. Neurotherapeutics. 20(3). 896–907. 10 indexed citations
7.
Cao, Quy, Qi N. Cui, Thorsten Alexander Bley, et al.. (2023). Orbital magnetic resonance imaging of giant cell arteritis with ocular manifestations: a systematic review and individual participant data meta-analysis. European Radiology. 33(11). 7913–7922. 10 indexed citations
8.
Addis, Victoria, et al.. (2022). Elevated IOP following a bladder filling protocol: A case report. American Journal of Ophthalmology Case Reports. 29. 101786–101786.
9.
Cui, Qi N., Lauren M. Stein, Samantha M. Fortin, & Matthew R. Hayes. (2021). The role of glia in the physiology and pharmacology of glucagon‐like peptide‐1: implications for obesity, diabetes, neurodegeneration and glaucoma. British Journal of Pharmacology. 179(4). 715–726. 45 indexed citations
10.
Sterling, Jacob, et al.. (2021). Glucagon-like peptide 1 receptor agonist use is associated with reduced risk for glaucoma. British Journal of Ophthalmology. 107(2). 215–220. 37 indexed citations
11.
Cui, Qi N., Ron D. Hays, Michelle E. Tarver, et al.. (2021). Vision-Targeted Health-Related Quality-of-Life Survey for Evaluating Minimally Invasive Glaucoma Surgery. American Journal of Ophthalmology. 229. 145–151. 8 indexed citations
12.
Sterling, Jacob, et al.. (2020). GLP-1 Receptor Agonist NLY01 Reduces Retinal Inflammation and Neuron Death Secondary to Ocular Hypertension. Cell Reports. 33(5). 108271–108271. 84 indexed citations
13.
Cui, Qi N., et al.. (2019). Repeated intravitreal injections of antivascular endothelial growth factors and risk of intraocular pressure medication use. Graefe s Archive for Clinical and Experimental Ophthalmology. 257(9). 1931–1939. 15 indexed citations
14.
Li, Tianjing, Jimmy T. Lê, Ron D. Hays, et al.. (2019). Patient-reported outcomes measures and patient preferences for minimally invasive glaucoma surgical devices. Eye. 34(1). 205–210. 12 indexed citations
15.
Cui, Qi N., S. Fudemberg, Arthur Resende, et al.. (2018). Validation of the structure–function correlation report from the heidelberg edge perimeter and spectral-domain optical coherence tomography. International Ophthalmology. 39(3). 533–540. 3 indexed citations
16.
Cui, Qi N., Jay M. Stewart, Ayman Naseri, et al.. (2016). Early Reoperation Rate, Complication, and Outcomes in Resident-performed Glaucoma Surgery. Journal of Glaucoma. 26(2). 87–92. 11 indexed citations
17.
Cui, Qi N. & Jay M. Stewart. (2014). Intravitreal Dexamethasone Implant (Ozurdex) as Primary Treatment for Diabetic Macular Edema. Investigative Ophthalmology & Visual Science. 55(13). 1780–1780. 2 indexed citations
18.
Lee, Roland, Qi N. Cui, Travis C. Porco, et al.. (2014). Association between Baseline Iris Thickness and Prophylactic Laser Peripheral Iridotomy Outcomes in Primary Angle-Closure Suspects. Ophthalmology. 121(6). 1194–1202. 47 indexed citations
19.
Cui, Qi N., et al.. (2013). Topotecan and Cyclophosphamide as Salvage Therapy in the Treatment of Retinoblastoma. Investigative Ophthalmology & Visual Science. 54(15). 3977–3977. 1 indexed citations
20.
Cui, Qi N., Travis C. Porco, Jeremy D. Keenan, & Shan C. Lin. (2011). The Cost-effectiveness Of Laser Peripheral Iridotomy Versus Lens Extraction For The Treatment Of Acute Primary Angle Closure. Investigative Ophthalmology & Visual Science. 52(14). 618–618. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026